Comparing Smoking Cessation Interventions Among Underserved Patients Referred for Lung Cancer Screening

Completed · Not applicable

Conditions studied: Smoking Cessation

In brief

To compare the effectiveness of four interventions to promote sustained, biochemically confirmed smoking abstinence for 6 months among underserved smokers referred for lung cancer screening at four large U.S. health systems.

Key facts

Study ID

NCT04798664

Run by

Abramson Cancer Center at Penn Medicine

People needed

3228

Starts

2021-05-17

Expected to finish

2025-04-29

Last updated by the study team

2026-02-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Current smoker (≥ 1 cigarettes per day, not including e-cigarettes)
• Has a low-dose computed tomography (LDCT) scan ordered by their physician
• Underserved, defined as one or more of the following: (a) Black, (b) Hispanic, (c) rural residence, or (d) low socioeconomic status (Defined as one or both of: high-school education or less, or household income <200% of the federal poverty line)
• Able to receive study invitation and screening, by virtue of showing up to a radiology location affiliated with a participating health system for the LDCT, or having a valid email address or telephone number on file with the health system
• Access to a cell phone with text messaging or the internet
• Aged 18 years or older

You may not qualify if…

• No cell phone

Where it is running

• Kaiser Permanente Southern California — Oakland, California, United States
• Henry Ford Health System — Detroit, Michigan, United States
• Geisinger — Danville, Pennsylvania, United States
• Lancaster General Health — Lancaster, Pennsylvania, United States
• University of Pennsylvania — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.